Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, May 21, 2024 | Back issues
Courthouse News Service Courthouse News Service

$100 Million Demand for Generic Drugs

PROVIDENCE, R.I. (CN) - CVS Pharmacy demands $100 million from three generic drugmakers, claiming K-V Pharmaceutical, Ethex Corp., and Nesher Pharmaceuticals abruptly cut off supplies at the end of 2008, due to their "flawed manufacturing processes" that led to recalls and a temporary FDA ban "on further manufacture of generic drugs."

The CVS Pharmacy chain says it's one of the biggest purchasers of generic drugs in the nation, and relied on defendants' assurances that they could supply it with generics, including Metoprolol Succinate Extended Release tablets, a blood pressure drug.

CVS said it had to turn to alternate suppliers, which charged "substantially increased prices." It claims it suffered more than $100 million in damages.

CVS is represented by Paul Dwyer Jr. with Edwards Angell Palmer & Dodge.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.